Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Ma Ai Thanda Han"'
Autor:
Tso‐Tsai Liu, He Qiu, Shi‐Yu Liu, Chieh Chien, Jen‐Hung Wang, Ming‐Wun Wong, Chih‐Hsun Yi, Lin Lin, Wei‐Yi Lei, Shu‐Wei Liang, Jui‐Sheng Hung, Jee‐Fu Huang, Chien‐Lin Chen, Ma Ai Thanda Han
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 38, Iss 10, Pp 1012-1019 (2022)
Abstract Metabolic‐associated fatty liver disease (MAFLD) is a growing global problem associated with increasing obesity prevalence. Lifestyle modifications are currently recommended, including weight reduction, exercise, and diet control. This stu
Externí odkaz:
https://doaj.org/article/ed2510a9a80d40ca8b48e71d76095fa1
Autor:
Ma Ai Thanda Han
Publikováno v:
Life, Vol 10, Iss 9, p 198 (2020)
Fatty liver syndrome is an emerging health problem in the world, due to the high prevalence of obesity and alcohol use disorder. Given the nature of the disease’s advancement to cirrhosis and liver-related complications, it is important to assess t
Externí odkaz:
https://doaj.org/article/f12a440bed194d8ab5c7c890341f93b0
Publikováno v:
Journal of Community Hospital Internal Medicine Perspectives, Vol 3, Iss 1, Pp 1-4 (2013)
Right ventricular (RV) myocardial infarction (MI) and pulmonary embolism (PE) are commonly recognized as two of the most challenging and vexing entities in clinical practice. When either is considered in a differential diagnosis, they warrant close c
Externí odkaz:
https://doaj.org/article/c9d650add7634eb2bd51b079c1493852
Autor:
Alexander H. Yang, Ma Ai Thanda Han, Niharika Samala, Bisharah S. Rizvi, Rachel Marchalik, Ohad Etzion, Elizabeth C. Wright, Liang Cao, Frances T. Hakim, Elizabeth Jones, Devika Kapuria, Dennis D. Hickstein, Daniel Fowler, Jennifer A. Kanakry, Christopher G. Kanakry, David E. Kleiner, Christopher Koh, Steven Z. Pavletic, Theo Heller
Publikováno v:
Transplantation and cellular therapy. 28(11)
Hepatic chronic graft-versus-host disease (cGVHD) causes morbidity and current diagnostic criteria are nonspecific. An accurate diagnosis is imperative because overdiagnosis can lead to unnecessary treatment with immunosuppressive agents and raising
Publikováno v:
Journal of Clinical and Translational Hepatology
Globally, the rise in prevalence of obesity and metabolic syndrome as a whole has been linked to increased access to processed foods, such as refined sugars and saturated fats. Consequently, nonalcoholic fatty liver disease (NAFLD) is on the rise in
Publikováno v:
American Journal of Gastroenterology. 117:e2020-e2021
Autor:
Jeffrey Gornbein, Rola Saouaf, Mazen Noureddin, Veronica Wendy Setiawan, Toluwalase Okubote, Ma Ai Thanda Han, Rohit Loomba, Yaron Rotman, Nader Baniesh, Naim Alkhouri, Nabil Noureddin, Kim Ramirez, Aarshi Vipani, Oladuni Cummings-John
Publikováno v:
Liver International. 40:2242-2251
BACKGROUND & AIMS Liver fibrosis assessed by liver biopsy is predictive of clinical liver events in patients with nonalcoholic fatty liver disease (NAFLD). Magnetic resonance elastography (MRE) correlates with liver biopsy in assessing liver fibrosis
Publikováno v:
Current Hepatology Reports. 19:63-69
Understand the placebo effect and optimize the design of nonalcoholic fatty liver disease (NAFLD) clinical trials. The placebo effect on histologic outcomes and liver fat on MRI-based imaging has been assessed in a systematic review and meta-analysis
Autor:
He Qiu, Tso-Tsai Liu, Jen-Hung Wang, Ming-Wun Wong, Chih-Hsun Yi, Lin Lin, Wei-Yi Lei, Jui-Sheng Hung, Chien-Lin Chen, Ma Ai Thanda Han
Publikováno v:
American Journal of Gastroenterology. 117:e1003-e1003
Autor:
Nikolaos Pyrsopoulos, Ma Ai Thanda Han
Publikováno v:
Clinics in liver disease. 25(3)
The incidence of alcoholic hepatitis is increasing while the mortality rate remains high. The single current available therapy for severe alcoholic hepatitis is administration of corticosteroids for patients with severe alcoholic hepatitis, which has